Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28066812 | 0.98 | KMT2A (0.40) | KMT2AMEN1MAPK1GLAEPHX2 | |
| SCHEMBL441785 | 0.81 | MEN1 (0.39) | KMT2AMEN1MAPK1GLAEPHX2 | |
| SCHEMBL3290691 | 0.81 | MEN1 (0.39) | KMT2AMEN1MAPK1GLAEPHX2 | |
| SCHEMBL9608676 | 0.80 | MEN1 (0.36) | KMT2AMEN1MAPK1EPHX2ALDH1A1 | |
| SCHEMBL13527866 | 0.79 | MEN1 (0.38) | KMT2AMEN1MAPK1GLAEPHX2 | |
| SCHEMBL112620 | 0.79 | MEN1 (0.38) | KMT2AMEN1MAPK1GLAEPHX2 | |
| SCHEMBL13638396 | 0.79 | MEN1 (0.38) | KMT2AMEN1MAPK1GLAEPHX2 | |
| SCHEMBL14838346 | 0.79 | MEN1 (0.38) | KMT2AMEN1MAPK1GLAEPHX2 | |
| SCHEMBL4903544 | 0.79 | EPHX2 (0.39) | KMT2AMEN1MAPK1GLAEPHX2 | |
| SCHEMBL19075500 | 0.78 | CYP17A1 (0.38) | KMT2AMEN1MAPK1GLAEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105612144-A | Method for preparing template agent | JOHNSON MATTHEY PLC | 2016-05-25 | — | — | CN | claimed |
| US-11762287-B2 | Onium salt compound, chemically amplified resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-09-19 | — | — | US | disclosed |
| CN-109438260-A | The preparation method of 1- adamantyl trimethylammonium hydroxide | 庄信万丰股份有限公司 | 2019-03-08 | — | — | CN | disclosed |
| CN-105612144-A | Method for preparing template agent | JOHNSON MATTHEY PLC | 2016-05-25 | — | — | CN | disclosed |
| US-9122155-B2 | Sulfonium salt, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2015-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11762287-B2 | Onium salt compound, chemically amplified resist composition and patterning process | IDUA, SLC6A5, SLC6A9 | KMT2A 2745/4885MEN1 3334/4885MAPK1 229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.